Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v12-EN
Language French English
Date Updated 2025-08-22 2025-08-22
Drug Identification Number 02231245 02231245
Brand name PMS-IPRATROPIUM PMS-IPRATROPIUM
Common or Proper name IPRATROPIUM IPRATROPIUM
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE
Strength(s) 250MCG 250MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 10x2ml 10x2ml
ATC code R03BB R03BB
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-04-24 2025-04-24
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status Yes Yes
Company comments Product anticipated to be back in stock as of August 29th. Limited supply will be available during this period followed by another anticipated BO period in early 2026. Product anticipated to be back in stock as of August 29th. Limited supply will be available during this period followed by another anticipated BO period in early 2026.
Health Canada comments